Palliative Care At Home for Patients with Dementia and Their Caregivers
A multi-site, single-blinded, parallel, randomized-controlled trial to evaluate the effectiveness of a novel model of in-home palliative care for dementia patients and their family caregivers. From inpatient and outpatient settings associated with four hospitals across New York City, patients with advanced dementia and their family caregivers will be randomized to intervention or augmented control.
• have advanced dementia, based on Global Deterioration Score (GDS)\>6
• impairment in at least one activity of daily living (ADL -which is inherent in this level of GDS)
• at least one hospitalization or ED visit within the last 12 months
• a physician who is primarily responsible for their dementia-related care whose clinical outpatient site is associated with one of the four Mount Sinai sites in Manhattan
• a family caregiver willing to enroll
• a residence in Manhattan where they are currently living (not in a long-term care facility)
• capacity to consent or a legal representative available to provide consent
• fluency in English or Spanish, or their legal representative must be fluent in English or Spanish
• age \>64.